Drug Database
Back to search

France· FR:68930729

GHRYVELIN 60 mg granulés pour suspension buvable en sachet

A macimorelin product containing acétate de macimoréline, registered in France by ATNAHS PHARMA NETHERLANDS (PAYS-BAS). The same ATC class is registered in 12 of our 19 countries.

ATC V04CD06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGHRYVELIN 60 mg granulés pour suspens…ATCV04CD06REGISTER NO.FR:68930729PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acétate de macimorélineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Macimorelin is registered in 12 of 19 countries.

Countries holding a registration under ATC V04CD06 (macimorelin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose
Search macimorelin products by name

Macimorelin · ATC V04CD06

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE DE MACIMORÉLINE
Manufacturer
ATNAHS PHARMA NETHERLANDS (PAYS-BAS)
Country
France (FR)
ATC code
V04CD06
ATC class
Macimorelin
Defined daily dose
35 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955086420
    1 sachet(s) polyéthylène basse densité (PEBD) aluminium papier de 1,817 mg

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for macimorelin.

Graded by severity as the source publishes them — 241 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check macimorelin against other medicinesHow interaction checks work

Macimorelin · interactions on record

398 records

  • 241 severe
  • 154 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Macimorelin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All macimorelin products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • United Kingdom (Northern Ireland) · Macimorelin Atnahs Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3aee5bd6-7d6d-4cad-8774-479b351db883
GET /v1/drugs/3aee5bd6-7d6d-4cad-8774-479b351db883?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68930729",
  "date_amm": "2019-01-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/18/1337",
  "substance": "ACÉTATE DE MACIMORÉLINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "granulés pour suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about macimorelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console